Monomeric G-Quadruplex-Based CpG Oligodeoxynucleotides as Potent Toll-Like Receptor 9 Agonists

被引:16
|
作者
Tu, Anh Thi Tram [1 ,2 ]
Hoshi, Kazuaki [2 ]
Ikebukuro, Kazunori [3 ]
Hanagata, Nobutaka [1 ,4 ]
Yamazaki, Tomohiko [1 ,2 ]
机构
[1] Hokkaido Univ, Grad Sch Life Sci, Div Life Sci, Kita Ku, Sapporo, Hokkaido 0600808, Japan
[2] Natl Inst Mat Sci NIMS, Res Ctr Funct Mat RCFM, Nanomed Grp, Tsukuba, Ibaraki 3050047, Japan
[3] Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan
[4] Natl Inst Mat Sci NIMS, Nanotechnol Innovat Stn, Tsukuba, Ibaraki 3050047, Japan
基金
日本学术振兴会;
关键词
DNA; STABILITY; SEQUENCE; RECOGNITION; LONG; SIZE;
D O I
10.1021/acs.biomac.0c00679
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Synthetic oligodeoxynucleotides (ODNs) containing unmethylated cytosine-phosphate-guanine (CpG) motifs trigger the immune response by stimulating endosomal Toll-like receptor (TLR) 9. Natural linear ODNs are susceptible to nuclease degradation, thereby limiting their clinical applications. Here, we designed monomeric G-quadruplex-based CpG ODNs (G4 CpG ODNs) containing CpG motifs in the central loop region of the G4 structure. The monomeric G4 CpG ODNs were more stable in serum than the linear ODNs. The monomeric G4 CpG ODNs containing two or three CpG motifs induced the production of immunostimulatory cytokines interleukin (IL)-6, IL-12, and interferon (IFN)-beta in mouse macrophage-like RAW264 cells. We also showed that the number of CpG motifs and the number of nucleotides between the CpG motif and G-tracts define the efficacy of the G4 CpG ODNs in activating TLR9. Incubating human peripheral blood mononuclear cells with G4 CpG ODNs promoted IL-6 and IFN-gamma production, confirming their stimulatory effects on human immune cells. Mice given intraperitoneal injections of G4 CpG ODNs produced higher plasma IL-6 compared with injections of linear ODNs. These findings provide further understanding of the parameters governing the immunostimulatory activity of G4 CpG ODNs, thereby providing insights into the rational design of highly potent G4 CpG ODNs for vaccine adjuvants.
引用
收藏
页码:3644 / 3657
页数:14
相关论文
共 50 条
  • [41] Direct binding of Toll-like receptor 9 to CpG-DNA
    不详
    IMMUNOBIOLOGY, 2004, 209 (4-6) : 324 - 324
  • [42] Toll-like receptor agonists and cancer
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (07) : 511 - 511
  • [43] Radiotherapy and Toll-Like Receptor Agonists
    Marabelle, Aurelien
    Filatenkov, Alex
    Sagiv-Barfi, Idit
    Kohrt, Holbrook
    SEMINARS IN RADIATION ONCOLOGY, 2015, 25 (01) : 34 - 39
  • [44] Correction: The Toll-like receptor ligand, CpG oligodeoxynucleotides, regulate proliferation and osteogenic differentiation of osteoblast
    Wenwen Yu
    Yi Zheng
    Hongyan Li
    Hongbing Lin
    Zhen Chen
    Yue Tian
    Huishan Chen
    Peipei Zhang
    Xiaowei Xu
    Yuqin Shen
    Journal of Orthopaedic Surgery and Research, 18
  • [45] Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
    A M Krieg
    Oncogene, 2008, 27 : 161 - 167
  • [46] Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
    Krieg, A. M.
    ONCOGENE, 2008, 27 (02) : 161 - 167
  • [47] Toll-like Receptor 9 Agonists as Adjuvants for Nanoparticle-Based Nicotine Vaccine
    Hu, Yun
    Smith, Daniel
    Frazier, Evan
    Zhao, Zongmin
    Zhang, Chenming
    MOLECULAR PHARMACEUTICS, 2021, 18 (03) : 1293 - 1304
  • [48] Regulation of bifurcated cytokine induction by surface charge of nanoparticles during interaction between CpG oligodeoxynucleotides and toll-like receptor 9
    Chinnathambi, Shanmugavel
    Pi, Xiaodong
    Xu, Mingsheng
    Hanagata, Nobutaka
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2015, 29 : 251 - 260
  • [49] Toll-like receptor 7 agonists are potent and rapid bronchodilators in guinea pigs
    Kaufman, Elad H.
    Fryer, Allison D.
    Jacoby, David B.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : 462 - 469
  • [50] Multiple toll-like receptor agonists act as potent adjuvants in the induction of autoimmunity
    Hansen, BS
    Hussain, RZ
    Lovett-Racke, AE
    Thomas, JA
    Racke, MK
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 172 (1-2) : 94 - 103